Zhongchao Inc. (ZCMD): Price and Financial Metrics


Zhongchao Inc. (ZCMD): $1.69

-0.03 (-1.74%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

ZCMD POWR Scores


  • ZCMD scores best on the value dimension, with a value rank ahead of 81.53% of US stocks.
  • ZCMD's strongest trending metric is stability; it's been moving down over the last 109 days.
  • ZCMD's current lowest rank is in the stability metric (where it is better than 20.64% of US stocks).

ZCMD Stock Summary

  • ZCMD's went public 1.19 years ago, making it older than only 0.46% of listed US stocks we're tracking.
  • For ZCMD, its debt to operating expenses ratio is greater than that reported by just 7.37% of US equities we're observing.
  • With a year-over-year growth in debt of -65.41%, Zhongchao Inc's debt growth rate surpasses only 4.59% of about US stocks.
  • Stocks that are quantitatively similar to ZCMD, based on their financial statements, market capitalization, and price volatility, are JOUT, BRC, ASTE, DAO, and EFOI.
  • ZCMD's SEC filings can be seen here. And to visit Zhongchao Inc's official web site, go to www.izcmd.com.

ZCMD Stock Price Chart Interactive Chart >

Price chart for ZCMD

ZCMD Price/Volume Stats

Current price $1.69 52-week high $5.25
Prev. close $1.72 52-week low $1.59
Day low $1.68 Volume 113,100
Day high $1.72 Avg. volume 1,295,180
50-day MA $1.75 Dividend yield N/A
200-day MA $1.85 Market Cap 30.56M

Zhongchao Inc. (ZCMD) Company Bio


Zhongchao, Inc. is a holding company that engages in the provision of healthcare information, education, and training services. It offers online and onsite health information services, healthcare education programs, and healthcare training products, consisting primarily of clinical practice training, open classes of medical topics, interactive case studies, academic conference & workshops, continuing education courses, articles & short videos with educational healthcare content to healthcare professionals as well as the public. The company was founded by Wei Guang Yang on April 16, 2019 and is headquartered in Shanghai, China.


ZCMD Latest News Stream


Event/Time News Detail
Loading, please wait...

ZCMD Latest Social Stream


Loading social stream, please wait...

View Full ZCMD Social Stream

Latest ZCMD News From Around the Web

Below are the latest news stories about Zhongchao Inc that investors may wish to consider to help them evaluate ZCMD as an investment opportunity.

Zhongchao Inc. Builds A Platform for Breast Cancer Tiered Diagnosis and Treatment Improvement To Promote the Equalization of Breast Cancer Diagnosis and Treatment Level

Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering patient management, online healthcare information, professional training and educational services, today announced that for the first half of 2021, around 100,000 users had completed the learnings through the Breast Cancer Tiered Diagnosis and Treatment Improvement Platform ("Platform") built and operated by the Company.

Yahoo | July 27, 2021

Zhongchao (NASDAQ:ZCMD) May Have Issues Allocating Its Capital

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Amongst...

Yahoo | July 14, 2021

Zhongchao Inc. Announces the Establishment of a New Subsidiary Ningxia Zhongxin Internet Hospital Co., Ltd. for Patient Management

Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering patient management, online healthcare information, professional training and educational services, announced the establishment of a new subsidiary Ningxia Zhongxin Internet Hospital Co., Ltd. ("Zhongxin Ningxia") under Shanghai Zhongxin Medical Technology Co., Ltd., a subsidiary of the Company. Zhongxin Ningxia will build an internet hospital ("Zhongxin Internet Hospital") focusing on inpatient m

Yahoo | July 1, 2021

Zhongchao Inc. Partners with a Subsidiary of AbbVie Inc. (NYSE: ABBV) for Medical Education Services

Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering online healthcare information, professional training and educational services, today announced the cooperation in physician education with AbbVie Pharmaceutical Trading (Shanghai) Co., Ltd. ("AbbVie Shanghai"), a subsidiary of AbbVie Inc (NYSE: ABBV) ("AbbVie"). AbbVie is a research-based global biopharmaceutical company. Pursuant to an agreement to facilitate such cooperation, Zhongchao and AbbV

Yahoo | June 16, 2021

Zhongchao Inc. Announces the On-Going One-Year Leukemia Education Project with Bethune Foundation and BeiGene Shanghai

Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering online healthcare information, professional training and educational services, announced the on-going one-year joint project of leukemia diagnosis and treatment courses (the "Project") that the Company has been hosting with Beijing Bethune Charitable Foundation ("Bethune Foundation") and BeiGene Pharmaceutical (Shanghai) Co., Ltd. ("BeiGene Shanghai"), a subsidiary of BeiGene, Ltd. (NASDAQ: BGNE;

Yahoo | June 3, 2021

Read More 'ZCMD' Stories Here

ZCMD Price Returns

1-mo N/A
3-mo -2.31%
6-mo -18.75%
1-year -40.70%
3-year N/A
5-year N/A
YTD -0.59%
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8887 seconds.